3Ng IO, Liu CL, Fan ST, et al. Expression of p-glycoprotein in hepatocellular carcinoma: a determinant of chemotherapy response[J]. Am J Clin Pathol, 2000,113(3):355-363
4Ros JE, Libbrecht L, Geuken M, et al.. High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease[J]. J Pathol,2003,200(5):553-560
5Nies AT, Konig J,Pfannschmidt M, et al.Expression of the multidrug resisitance proteins MRP2 and MRP3 in human hepatocellularcarcinoma[J].Int J Cancer, 2001, 94(4):492-499
6Volm M. Multidrug resistance and its reversal[J]. Anticancer Res,1998, 18:2905-2918
7Borst P, Evers R, Kool M. A family of drug transporters : the multidrug resistance associated proteins[J]. J Natl Cancer Inst, 2000,92(6):1295-1302
8Hartmann G, Cheung AK, Piquette-Miller M. Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia[J]. J Pharmacol Exp Ther,2002,303(1):273-81
9Sauna ZE, Ambudkar SV. Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein. Proc Natl Acad Sci USA, 2000, 97:2515-2520.
10Nishimura Y, Ishii A, Kobayashi P, et al. Expression and function of mouse Fas antigen on immature and mature T cells. J Immunol, 1995, 154: 4395-4403.
4[1]Candiano G,Bruschi M,Musante L,et al.Blue silver:a very sensitive colloidal Coomassie G-250 staining for proteome analysis.Electrophoresis,2004,25 (9):1327 -1333.
5[3]Zhang D,Fan D.Multidrug resistance in gastric cancer:recent research advances and ongoing therapeutic challenges.Expert Rev Anticancer Ther,2007,7(10):1369-1378.
6[4]Lacueva J,Perez-Ramos M,Soto JL,et al.Muhidrug resistance-associated protein(MRP1)gene is strongly expressed in gastric carcinomas.Analysis by immunohistochemistry and real-time quantitative RT-PCR.Histopathology,2005,46(4):389-395.
7[5]Lage H.Proteomics in cancer cell research:an analysis of therapy resistance.Pathol Res Pract,2004,200(2):105-117.
8[6]Righetti PG,Castagna A,Antonioli P,et al.Proteomic approaches for studying chemoresistance in cancer.Expert Rev Proteomics,2005,2 (2):215-228.
9[7]Schramm A,Apostolov O,Sitek B,et al.Prateomies:techniques and applications in cancer research.Klin Padiatr,2003,215(6):293-297.
